Marshall I., Ugrasbul F., Manginello F., et al. Congenital hypopituitarism as a cause of undetectable estriol levels in maternal triple-marker screen. J Clin Endocrinol Metab. 2003;88:4144-4148.
2.
Geffner, MEHypopituitarism in childhood. Cancer Control. 2002;9:212-222.
3.
Becerra JE, Khoury MJ, Cordero JF, Erickson DJDiabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case control study. Pediatrics. 1990;85:1-9.
4.
Li G., Shao P., Sun X., Wang Q., Zhang L.Magnetic resonance imaging and pituitary function in children with panhypopituitarism . Horm Res Paediatr. 2010;73: 205-209.
5.
Farrell T., Neale L., Cundy T.Congenital anomalies in the offspring of women with type 1, type 2, and gestational diabetes. Diabet Med. 2002;19:322-326.
6.
Martinez-Frias ML, Bermejo E., Rodriguez-Pinilla E., Preito L., Frias JLEpidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet. 1998;78:140-145.
7.
Lin CH, Wen SF, Wu YH, Huang YY, Huang MJThe postpartum metabolic outcomes of women with previous gestational diabetes mellitus. Chang Gung Med J. 2005;28: 794-800.
8.
Mills JL, Knopp RH, Simpson JL, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med. 1988;318:671-676.
9.
Wyatt JW, Frias JL, Hoyme HE, et al; the IONS study group.Congenital anomaly rate in offspring of pre-gestational diabetic women treated with insulin lispro during pregnancy. Diabet Med. 2005;22:803-807.
10.
Frias JL, Frias JP, Frias PA, Martinez-Frias MLInfrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus. Am J Med Genet. 2007; 143A:2904-2909.
11.
Brown RS, Bhatia V., Hayes E.An apparent cluster of congenital hypopituitarism in central Massachusetts: magnetic resonance imaging and hormonal studies. J Clin Endocrinol Metab. 1991;72:12-18.
12.
Wentzel P., Welsh N., Erikson UJDevelopmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes. 1999;48:813-820.
13.
Li R., Chase M., Jung SK, Smith PJ, Loeken MRHypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab. 2005;289: E591-E599.
14.
Li R., Thorens B., Loeken MRExpression of the gene encoding the high Km-glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia. 2007 ;50:682-689.
15.
Chappell JH , Wang XD, Loeken MRDiabetes and apoptosis: neural crest cells and neural tube. Apoptosis. 2009;14:1472-1483.
16.
Terzic J., Saraga-Babic M.Expression pattern of Pax3 ad Pax6 genes during human embryogenesis. Int J Dev Biol. 1999;43:501-508.
17.
Kelberman D. , Rizzoli K., Lovell-Badge R., Robinson I., Dattani MTGenetic regulation of pituitary gland development in human and mouse. Endocr Rev. 2009;30: 790-829.
18.
Osamaru R., Egashira, N.Recent developments in molecular embryogenesis and molecular biology of the pituitary. In: Lloyd RV, ed. Endocrine Pathology: Differential Diagnosis and Molecular Advances. 2nd ed. New York, NY: Springer; 2010:91-102.
